CLINICAL_TRIALS
trial_result
· 2018-02-07
Clinical Trial Update: Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis [Phase 2]
Summary
Phase 2 trial evaluating four dose regimens of oral albaconazole in distal subungual onychomycosis; efficacy and safety results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stiefel, a GSK Company | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED | Results posted: 2018-02-07